-
Villeneuve teases James Bond casting at Los Angeles museum gala
-
Thames Water seeks to delay £12bn in debt repayments
-
Nottinghamshire launches specialist rural crime policing team
-
Newark boxing gym expands alternative education programme
-
China confirms talks over possible Xi-Putin-Trump summit
-
Democrats consider impeachment drive against Defence Secretary Hegseth
-
Rail journey offers a slower route to a Berlin city break
-
Energy bill plan could use HMRC income data to target support
-
Arsenal control title race as Manchester United fall into bottom three
-
Business owner earning £6,000 a month tackles £70,000 debt
-
Suspected Krakow gunman dies after attack that killed six
-
Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent
-
Carrick backs Dalot after hostile reception from Manchester United fans
-
Comet returns as online electrical marketplace 14 years after collapse
-
Fire in Northern China Apartment Building Kills 14
-
Solihull Hospital Performs First Robotic-Assisted Gynaecological Cancer Surgeries
-
Apple’s 20th Anniversary iPhone to Skip Action Button for Camera Control Integration
-
Nvidia CEO Jensen Huang Admits Infidelity Amid Spy Investigation
-
Family of Woman Who Died at Voting Station Condemns Official Silence
-
Ted Scheinman’s Journey Through Depression and Electroconvulsive Therapy
-
Karen Wazen Launches First Standalone Boutiques in Cairo
-
Phoenix Symphony Resumes Performances Amid Financial Uncertainty
-
A Holiday-Season Moment for Penny-Stock Followers and Microcap Visionaries as Elektros Moves Its EV Patent Forward
-
Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
-
IGC Pharma Reports Third Quarter 2026 Financial Results and Provides Business Update
-
United States Antimony Corporation Announces Webcast Time set for Thursday, November 12, 2026 at 4:15 PM ET to Report on Third Quarter and Nine Months Ended September 30, 2026 Financial and Operating Results
-
Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
-
Ai4 Celebrates Successful Debut of Applied AI Research Conference (AAIRC), Bridging Academic Research and Industry Innovation
-
Releaf Unveils UK-first THCV for Weight Management
-
Gabriel Provides Corporate Update
-
Hancock Health Expands Robot Specimen Delivery to Parkway Building, Adding Scheduled and On-Demand Runs to the Lab
-
AsiaFIN's Insite MY Holdings and MENA Insite MY Sign Distributorship Agreement and Announce Second Bank Customer in Saudi Arabia
-
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
-
Nextech3D.ai Closes $720,000 Management-Led Private Placement
-
CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
Silver Storm Reports Concentrate Deliveries from La Parrilla
-
Ispire Technology Inc. Reports First Quarter Fiscal Year 2027 Financial Results
-
HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
Hillcrest and Equipmake Sign Definitive Agreement to Jointly Develop and License ZVS Inverter Technology for Heavy-Duty Electric Vehicles
-
Tintina Mines Intersects 460m at 0.50% CuEq at the Dos Amigos Copper-Gold Project in Chile
-
Pace Launches Three-Business-Day Culture-Based 'L. pneumophila' Testing
-
Opti Digital Launches NEXA, an AI-Powered Intelligence Layer
-
DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 09
-
Making Your Home Safer for Aging Parents: Accessibility Renovations That Add Value
-
New 401k Gold IRA Investment Guide Explains the Best Way to Invest in Gold for Retirement (2026 Update)
-
Eylsia Nicolas Launches Global "Wake Me Up" Franchise After Surpassing 100 Million Meta Views in One Week
-
AELF Acquires Two Airbus A330 Aircraft on Lease to Wamos Air
-
CCA Industries, Inc. Reports Results of Operations for the Quarter and Nine Months ended August 31, 2026
-
Penny Stock Enthusiasts, Microcap Visionaries & Institutional Investors: A Moment to Watch as Elektros Works to Advance Its Patented EV Technology Toward a First Prototype
Pacific Edge Labs Publishes More Than 120 Independent Lab Reports, Each Listed With the Testing Lab's Own ID
Researchers can see which laboratory tested each lot and check the report with that lab before ordering, on the company's official site, pacificedgelabs.io.
SACRAMENTO, CA / ACCESS Newswire / November 9, 2026 / Pacific Edge Labs, a U.S. supplier of research peptides and laboratory research materials, today announced that its public certificate-of-analysis library now lists more than 120 original reports from two independent laboratories, Freedom Diagnostics and Vanguard Laboratory, including 44 reports from September 2026. Each listing shows the testing laboratory, the lab's own report ID and the report date. Reports from Freedom Diagnostics also open directly on the laboratory's own website.
"Researchers shouldn't have to take a supplier's word for purity," the Pacific Edge Labs quality team said. "Putting the lab's own record next to every report is the simplest way we know to earn that trust."
The library is at https://www.pacificedgelabs.io/test-results/. Every product page links its original reports, and the company's support team can confirm which lot is currently shipping.
Pacific Edge Labs also reminds researchers that pacificedgelabs.io is its only official store. Look-alike websites and pages that use the company's name are not affiliated with Pacific Edge Labs; the company's Official Websites page (https://www.pacificedgelabs.io/official-websites/) lists the sites it operates.
About Pacific Edge Labs
Pacific Edge Labs is a U.S.-based supplier of research peptides and laboratory research compounds for qualified researchers and professional laboratory environments. Products are sold for laboratory research use only. They are not intended for human or veterinary use and have not been evaluated by the U.S. Food and Drug Administration. Learn more at https://www.pacificedgelabs.io.
Media contact
Pacific Edge Labs quality team
[email protected]
+1 323-303-3891
SOURCE: Pacific Edge Labs LLC
View the original press release on ACCESS Newswire
N.Walker--AT